1. Home
  2. OOMA vs RGNX Comparison

OOMA vs RGNX Comparison

Compare OOMA & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OOMA
  • RGNX
  • Stock Information
  • Founded
  • OOMA 2003
  • RGNX 2008
  • Country
  • OOMA United States
  • RGNX United States
  • Employees
  • OOMA N/A
  • RGNX N/A
  • Industry
  • OOMA EDP Services
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • OOMA Technology
  • RGNX Health Care
  • Exchange
  • OOMA Nasdaq
  • RGNX Nasdaq
  • Market Cap
  • OOMA 379.7M
  • RGNX 356.7M
  • IPO Year
  • OOMA 2015
  • RGNX 2015
  • Fundamental
  • Price
  • OOMA $14.42
  • RGNX $7.27
  • Analyst Decision
  • OOMA Strong Buy
  • RGNX Buy
  • Analyst Count
  • OOMA 6
  • RGNX 12
  • Target Price
  • OOMA $16.60
  • RGNX $33.36
  • AVG Volume (30 Days)
  • OOMA 98.8K
  • RGNX 672.5K
  • Earning Date
  • OOMA 03-04-2025
  • RGNX 02-28-2025
  • Dividend Yield
  • OOMA N/A
  • RGNX N/A
  • EPS Growth
  • OOMA N/A
  • RGNX N/A
  • EPS
  • OOMA N/A
  • RGNX N/A
  • Revenue
  • OOMA $253,431,000.00
  • RGNX $84,327,000.00
  • Revenue This Year
  • OOMA $10.50
  • RGNX $2.23
  • Revenue Next Year
  • OOMA $6.09
  • RGNX $250.77
  • P/E Ratio
  • OOMA N/A
  • RGNX N/A
  • Revenue Growth
  • OOMA 9.45
  • RGNX N/A
  • 52 Week Low
  • OOMA $6.50
  • RGNX $6.56
  • 52 Week High
  • OOMA $17.00
  • RGNX $28.80
  • Technical
  • Relative Strength Index (RSI)
  • OOMA 46.07
  • RGNX 41.90
  • Support Level
  • OOMA $14.43
  • RGNX $6.92
  • Resistance Level
  • OOMA $15.65
  • RGNX $7.79
  • Average True Range (ATR)
  • OOMA 0.47
  • RGNX 0.44
  • MACD
  • OOMA -0.02
  • RGNX -0.04
  • Stochastic Oscillator
  • OOMA 34.32
  • RGNX 19.40

About OOMA Ooma Inc.

Ooma Inc is a communications services company. It is a smart software-as-a-service ("SaaS") and unified communications platform that deliver voice and collaboration features including messaging, intelligent virtual attendants and video conferencing, and residential phone service provides PureVoice high-definition voice quality, advanced functionality and integration with mobile devices. Its services rely upon the following main elements: multi-tenant cloud service, on-premise devices, desktop and mobile applications, and calling platforms. Ooma generates revenues from the sale of subscriptions and other services.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

Share on Social Networks: